Stock Track | BEIGENE Plummets 7.45% in Pre-market on Earnings Caution and Below-Guide Revenue Outlook

Stock Track

02/26

BEIGENE LTD's American depositary shares experienced a significant pre-market plummet of 7.45% on Thursday, reflecting heavy selling pressure at the market open.

The sharp decline comes as the innovative drug company is scheduled to release its 2025 financial report, with investors exhibiting caution and negative expectations ahead of the earnings announcement. Market sentiment was further dampened by the company's 2026 revenue guidance, which fell below analyst estimates, contributing to the sell-off.

The stock's drop also reflected broader weakness in the pharmaceutical sector, where innovative drug stocks led market declines during the session. As a leading component of several pharmaceutical ETFs, BEIGENE's performance is closely watched by investors tracking the healthcare industry's transition from research and development to commercialization.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1181796814"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1181796814\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1181796814?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-26 23:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181796814","market":"us","top_or_hot":-1,"title":"Stock Track | BEIGENE Plummets 7.45% in Pre-market on Earnings Caution and Below-Guide Revenue Outlook","media":"Stock Track","content":"<p>BEIGENE LTD's American depositary shares experienced a significant pre-market plummet of 7.45% on Thursday, reflecting heavy selling pressure at the market open.</p><p>The sharp decline comes as the innovative drug company is scheduled to release its 2025 financial report, with investors exhibiting caution and negative expectations ahead of the earnings announcement. Market sentiment was further dampened by the company's 2026 revenue guidance, which fell below analyst estimates, contributing to the sell-off.</p><p>The stock's drop also reflected broader weakness in the pharmaceutical sector, where innovative drug stocks led market declines during the session. As a leading component of several pharmaceutical ETFs, BEIGENE's performance is closely watched by investors tracking the healthcare industry's transition from research and development to commercialization.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | BEIGENE Plummets 7.45% in Pre-market on Earnings Caution and Below-Guide Revenue Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | BEIGENE Plummets 7.45% in Pre-market on Earnings Caution and Below-Guide Revenue Outlook\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-02-26 23:33</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>BEIGENE LTD's American depositary shares experienced a significant pre-market plummet of 7.45% on Thursday, reflecting heavy selling pressure at the market open.</p><p>The sharp decline comes as the innovative drug company is scheduled to release its 2025 financial report, with investors exhibiting caution and negative expectations ahead of the earnings announcement. Market sentiment was further dampened by the company's 2026 revenue guidance, which fell below analyst estimates, contributing to the sell-off.</p><p>The stock's drop also reflected broader weakness in the pharmaceutical sector, where innovative drug stocks led market declines during the session. As a leading component of several pharmaceutical ETFs, BEIGENE's performance is closely watched by investors tracking the healthcare industry's transition from research and development to commercialization.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ONC","symbol_name":"百濟神州","start_time":0,"source_url":"","article_id":"1181796814","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181796814","pubTimestamp":1772119992,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"BEIGENE LTD's American depositary shares experienced a significant pre-market plummet of 7.45% on Thursday, reflecting heavy selling pressure at the market open.The sharp decline comes as the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ONC":"百济神州"},"translate_title":"个股追踪|百济神州盘前暴跌7.45%因财报谨慎及营收前景低于指引","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ONC":1},"content_text":"BEIGENE LTD's American depositary shares experienced a significant pre-market plummet of 7.45% on Thursday, reflecting heavy selling pressure at the market open.The sharp decline comes as the innovative drug company is scheduled to release its 2025 financial report, with investors exhibiting caution and negative expectations ahead of the earnings announcement. Market sentiment was further dampened by the company's 2026 revenue guidance, which fell below analyst estimates, contributing to the sell-off.The stock's drop also reflected broader weakness in the pharmaceutical sector, where innovative drug stocks led market declines during the session. As a leading component of several pharmaceutical ETFs, BEIGENE's performance is closely watched by investors tracking the healthcare industry's transition from research and development to commercialization.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}